Skip to main content

Advertisement

Log in

Otomycosis in Iran: A Review

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

Fungal infection of the external auditory canal (otitis externa and otomycosis) is a chronic, acute, or subacute superficial mycotic infection that rarely involves middle ear. Otomycosis (swimmer’s ear) is usually unilateral infection and affects more females than males. The infection is usually symptomatic and main symptoms are pruritus, otalgia, aural fullness, hearing impairment, otorrhea, and tinnitus. Fungal species such as yeasts, molds, dermatophytes, and Malassezia species are agents for otitis externa. Among molds, Aspergillus niger was described as the most common agent in the literature. Candida albicans was more prevalent than other yeast species. Otomycosis has a worldwide distribution, but the prevalence of infection is related to the geographical location, areas with tropical and subtropical climate showing higher prevalence rates. Otomycosis is a secondary infection and is more prevalent among swimmers. As a result, a higher incidence is reported in summer season, when more people interested in swimming. Incidence of otomycosis in our review ranged from 5.7 to 81 %, with a mean value of 51.3 %. Our results showed that 78.59 % of otomycosis agents were Aspergillus, 16.76 % were Candida species, and the rest (4.65 %) were other saprophytic fungi. Among Iranian patients, incidence of infection was highest in summer, followed by autumn, winter, and spring. In Iran, otomycosis was most prevalent at the age of 20–40 years and the lowest prevalence was associated with being <10 years old. The sex ratio of otomycosis in our study was (M/F) 1:1.53.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Bineshian F, Irajian G, Koochak-Alavi SK, Fredonian MR. A study on the frequency of fungal agents in otitis externa in Semnan. Iran J Pathol. 2006;1(4):141–4.

    Google Scholar 

  2. Saki N, Rafiei A, Nikakhlagh S, Amirrajab N, Saki S. Prevalence of otomycosis in Khouzestan province, south-west Iran. J Laryngol Otol. 2013;127(01):25–7.

    Article  CAS  PubMed  Google Scholar 

  3. Munguia R, Daniel SJ. Ototopical antifungals and otomycosis: a review. Int J Pediatr Otorhinolaryngol. 2008;72(4):453–9.

    Article  PubMed  Google Scholar 

  4. Nowrozi H, Arabi FD, Mehraban HG, Tavakoli A, Ghooshchi G. Mycological and clinical study of otomycosis in Tehran, Iran. Bull Environ Pharmacol Life Sci. 2014;3(2):29–31.

    Google Scholar 

  5. Barati B, Okhovvat S, Goljanian A, Omrani M. Otomycosis in central iran: a clinical and mycological study. Iran Red Crescent Med J. 2011;13(12):873–6.

    PubMed Central  CAS  PubMed  Google Scholar 

  6. Vennewald I, Klemm E. Otomycosis: diagnosis and treatment. Clin Dermatol. 2010;28(2):202–11.

    Article  PubMed  Google Scholar 

  7. Jia X, Liang Q, Chi F, Cao W. Otomycosis in Shanghai: aetiology, clinical features and therapy. Mycoses. 2012;55(5):404–9.

    Article  PubMed  Google Scholar 

  8. Elahi S, Zaini F. First case report of otomycosis due to hendersonula toruloidea. Acta Med Iran. 1994;32:131–5.

    Google Scholar 

  9. Pakshir K, Sabayan B, Javan H, Karamifar K. Mycoflora of human external auditory canal in Shiraz, southern Iran. Iran Red Crescent Med J. 2008;10(1):27–9.

    Google Scholar 

  10. Kazemi AH, Ghiaei S. Survey of otomycosis in north-western area of Iran, 1997–2004. J Manzandaran Univ Med Sci. 2005;48:112–9.

    Google Scholar 

  11. Shokoohi T, Ahanjan M, Kasiri AM. Bacteriological and mycological study of external otitis in patients referred to ENT clinic of Boo Ali Sina hospital in Sari in summer 1999. J Mazandran Uni Med Sci. 2001;21:1–10.

    Google Scholar 

  12. Viswanatha B, Sumatha D, Vijayashree MS. Otomycosis in immunocompetent and immunocompromised patients: comparative study and literature review. Ear Nose Throat J. 2012;91(3):114–21.

    PubMed  Google Scholar 

  13. Yeganeh Mogadam A, Asadi MA, Dehghani R, Hooshyar H. The prevalence of otomycosis in Kashan, Iran, during 2001–2003. Jundishapur J Microbiol. 2011;2(1):18–21.

    Google Scholar 

  14. Sheikh MS, Qazi B, Rameen B. Otomycosis in Khozistan. Indian J Otolaryngol Head Neck Surg. 1993;45(2):73–7.

    Google Scholar 

  15. Prasad SC, Kotigadde S, Shekhar M, Thada ND, Prabhu P, D’Souza T. et al. (2014) Primary otomycosis in the Indian subcontinent: predisposing factors, microbiology, and classification. Int J Microbiol. 2014:Article ID 636493

  16. Anwar K, Gohar MS. Otomycosis; clinical features, predisposing factors and treatment implications. Pak J Med Sci. 2014;30(3):564–7.

    PubMed Central  PubMed  Google Scholar 

  17. Latha R, Sasikala R, Muruganandam N. Chronic otomycosis due to Malassezia spp. J Global Infect Dis. 2010;2(2):189–90.

    Article  CAS  Google Scholar 

  18. Sephidgar A, Kyakajouri K, Meyrzaei M, Sharifi F. Fungal infections of external ear canal in patients with otomycosis, Babol, 1991–2001. J Babol Med Sci. 2002;4(1):25–9.

    Google Scholar 

  19. Zarei Mahmoudabadi A, Abshirini H, Rahimi R. Fungal flora of hearing aid moulds and ear canal in hearing aid wearers in school children in Ahvaz, Iran. Jundishapur J Microbiol. 2009;2(1):22–4.

    Google Scholar 

  20. Zarei Mahmoudabadi A, Masoomi SA, Mohammadi H. Clinical and mycological studies of otomycosis. Pak J Med Sci. 2010;26(1):187–90.

    Google Scholar 

  21. Kaur R, Mittal N, Kakkar M, Aggarwal AK, Mathur MD. Otomycosis: a clinicomycologic study. Ear Nose Throat J. 2000;79(8):606–9.

    CAS  PubMed  Google Scholar 

  22. Sturgulewski SK, Bankaitis A, Klodd DA, Haberkamp T. What’s still growing on your patients’ hearing aids? Hear J. 2006;59(9):45–6.

    Article  Google Scholar 

  23. Ozcan KM, Ozcan M, Karaarslan A, Karaarslan F. Otomycosis in Turkey: predisposing factors, aetiology and therapy. J Laryngol Otol. 2003;117(01):39–42.

    Article  PubMed  Google Scholar 

  24. Paulose K, Khalifa SA, Shenoy P, Sharma R. Mycotic infection of the ear (otomycosis): a prospective study. J Laryngol Otol. 1989;103(01):30–5.

    Article  CAS  PubMed  Google Scholar 

  25. Jackman A, Ward R, April M, Bent J. Topical antibiotic induced otomycosis. Int J Pediatr Otorhinolaryngol. 2005;69(6):857–60.

    Article  PubMed  Google Scholar 

  26. Ghiacei S. Survey of otomycosis in north-western area of Iran. Med J Mashhad Univ Med Sci. 2001;43:85–7.

    Google Scholar 

  27. Pontes ZBVdS, Silva ADF, Lima EDO, Guerra MDH, Oliveira NMC, Carvalho MDFFP, et al. Otomycosis: a retrospective study. Braz J Otorhinolaryngol. 2009;75(3):367–70.

    Article  PubMed  Google Scholar 

  28. Szigeti G, Sedaghati E, Zarei Mahmoudabadi A, Naseri A, Kocsube S, Vágvölgyi C, et al. Species assignment and antifungal susceptibilities of black aspergilli recovered from otomycosis cases in Iran. Mycoses. 2012;55(4):333–8.

    Article  PubMed  Google Scholar 

  29. Kiakojuri K, Roushan MRH, Sepidgar SAA. Suction clearance and 2 % topical miconazole versus the same combination with acidic drops in the treatment of otomycosis. Southeast Asian J Trop Med Public Health. 2007;38:749–53.

    PubMed  Google Scholar 

  30. Chadeganipour M, Shadzi S, Nilipour S, Ahmadi G. Airborne fungi in Isfahan and evaluation of allergenic responses of their extracts in animal model. Jundishapur J Microbiol. 2011;3(4):155–60.

    Google Scholar 

  31. Rajabnia R, Mahdavi Omran S, Majidian A, Aghajanpour S, Kiakojori K. Comparison of fungal flora in patients with acute otitis externa and healthy subjects. J Babol Univ Med Sci. 2010;12(3):32–7.

    Google Scholar 

  32. Moharram AM, Ahmed HE, Salma AMN. Otomycosis in Assiut, Egypt. J Basic Appl Mycol (Egypt). 2013;4:1–11.

    Google Scholar 

  33. Değerli K, Ecemiş T, Günhan K, Başkesen T, Kal E. Agents of otomycosis in Manisa region, Turkey, 1995–2011. Mikrobiyol Bul. 2012;46(1):79–87.

    PubMed  Google Scholar 

  34. García-Agudo L, Aznar-Marín P, Galán-Sánchez F, García-Martos P, Marín-Casanova P, Rodríguez-Iglesias M. Otomycosis due to filamentous fungi. Mycopathologia. 2011;172(4):307–10.

    Article  PubMed  Google Scholar 

  35. Badr Jabir H, Naeem Abbas F, Muhsin Khalaf R. In vitro assessment of antifungal potential of apple cider vinegar and acetic acid versus fluconazole in clinical isolates of otomycosis. Thi Qar Med J. 2011;5(1):126–33.

    Google Scholar 

  36. Fayemiwo S, Ogunleye V, Adeosun A, Bakare R. Prevalence of otomycosis in Ibadan: a review of laboratory reports. Afr J Med Med Sci. 2010;39:219–22.

    PubMed  Google Scholar 

  37. Kiakojuri K, Rajabnia R, Jalili B, Khafri S, Mahdavi Omran SS. Otomycosis in adolescent patients who referred to therapeutical centers, Babol, report of 56 cases. Jundishapur J Microbiol 2015;8:17138 (in press).

  38. Berjis N, Okhovat SA, Soleimani Koujani Z, Baradaran S. Comparing the therapeutic effect of clotrimazole and tolnaftate in treating the variety of fungal species producing otomycosis in two educational hospital, Isfahan, Iran. J Isfahan Med Sch. 2012;29(164):2117–26.

    Google Scholar 

  39. Ettehad GH, Refahi S, Nemmati A, Pirzadeh A, Daryani A. Microbial and antimicrobial susceptibility patterns from patients with chronic otitis media in Ardebil. Int J Trop Med. 2006;1(2):62–5.

    Google Scholar 

  40. Mikaeili A, Nazari S. Aspergillus and otomycosis in Kermanshah Iran. 5th Advances against Aspergillosis, 26–28 January 2012—Istanbul, Turkey. 2012

  41. Balouchi M, Berjis N, Okhovat A. Investigation of ear fungal infection. J Isfahan Med Sch. 2006;82(4):72–5.

    Google Scholar 

  42. Nemati S, Hassanzadeh R, Jahromi SK, Abadi ADN. Otomycosis in the north of Iran: common pathogens and resistance to antifungal agents. Eur Arch Otorhino Laryngol. 2014;271(5):953–7.

    Article  Google Scholar 

  43. Kiakojuri K, Roushan MRH, Sepidgar SAA. Suction clearance and 2% topical miconazole versus the same combination with acidic drops in the treatment of otomycosis. Southeast Asian J Trop Med Public Health. 2007;38:749–53.

    PubMed  Google Scholar 

  44. Afshari MA, Kachooei R, Ajalloeian M. Assessment of prevalence of otomycosis in ENT clinic in Baqiyatallah (AS) hospital. J Mil Med. 2005;2:121–4.

    Google Scholar 

  45. Jalali MM, Kousha AAR, Hashemi SJ, Forghan Parast K, Karimi HR. Frequency of fungi in the middle ear effusion of patients suffering from serous otitis media in Rasht Amiralmomenin hospital (2004–2005). J Ilam Univ Med Sci. 2006;14(1):39–43.

    Google Scholar 

  46. Zarei Mahmoudabadi A. Mycological studies in 15 cases of otomycosis. Pak J Med Sci. 2006;22(4):486–8.

    Google Scholar 

  47. Yaganeh Moghadam A, Asadi M, Dehghani R, Zarei Mahmoudabadi A, Rayegan F, Hooshyar H, Khorshidi A. Evaluating the effect of a mixture of alcohol and acetic acid for otomycosis therapy. Jundishapur J Microbiol. 2010;3(2):66–70.

    Google Scholar 

  48. Desai KJ, Malek SS, Italia IK, Jha S, Pndya V, Shah H. Fungal spectrum in otomycosis at tertiary care hospital. Natl J Integr Res Med. 2012;3(5):58–61.

    Google Scholar 

  49. Aneja K, Sharma C, Joshi R. Fungal infection of the ear: a common problem in the north eastern part of Haryana. Int J Pediatr Otorhinolaryngol. 2010;74(6):604–7.

    Article  CAS  PubMed  Google Scholar 

  50. Adoubryn K, N’gattia V, Kouadio-Yapo G, Nigué L, Zika D, Ouhon J. Epidemiology of otomycoses at the university hospital of Yopougon (Abidjan-Ivory Coast). J Mycol Med. 2014;24(2):e9–15.

    Article  CAS  PubMed  Google Scholar 

  51. Deshmukh J, Surpam R, Band A, Jalgaon KD, India M. Mycological study of Aspergillus infections in otomycosis in eastern part of Maharashtra. Int J Health Sci Res. 2014;4(10):77–82.

    Google Scholar 

  52. Gutiérrez PH, Álvarez SJ, Sanudo E, García LG-C, Sánchez CR, VallejoValdezate L. Presumed diagnosis: otomycosis. A study of 451 patients. Acta Otorrinolaringol Esp. 2005;56:181–6.

    Article  Google Scholar 

  53. Panchal P, Pethani J, Patel D, Rathod S, Shah P. Analysis of various fungal agents in clinically suspected cases of otomycosis. Indian J Basic Appl Med Res. 2013;2:865–9.

    Google Scholar 

  54. Zarei Mahmoudabadi A, Seifi Z, Gharaghani M. Lamisil, a potent alternative antifungal drug for otomycosis. Adv Med Mycol. 2015;1(1):18–21.

    Google Scholar 

  55. Sagit M, Somdas MA, Korkmaz F, Akcadag A. The ototoxic effect of intratympanic terbinafine applied in the middle ear of rats. J Otolaryngol Head Neck Surg. 2013;42(1):13.

    Article  PubMed Central  PubMed  Google Scholar 

  56. Alnawaiseh S, Almomani O, Alassaf S, Elessis A, Shawakfeh N, Altubeshi K, et al. Treatment of otomycosis: a comparative study using miconazole cream with clotrimazole otic drops. J Roy Med Serv. 2011;18(3):34–7.

    Google Scholar 

  57. Philip A, Thomas R, Job A, Sundaresan VR, Anandan S, Albert RR. Effectiveness of 7.5 percent povidone iodine in comparison to 1 percent clotrimazole with lignocaine in the treatment of otomycosis. ISRN Otolaryngol. 2013. doi:10.1155/2013/239730.

  58. Zarei Mahmoudabadi A, Abshirini H, Ahmadi K, Moghimipour E. Lamisil ear drop, a newly prepared antifungal for otomycosis treatment. In: The 3rd Iranian Congress of Clinical Microbiology (ICCM), Shiraz, Iran, 6–8 Oct, 2009. (Abstract book), p. 40.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ali Zarei Mahmoudabadi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gharaghani, M., Seifi, Z. & Zarei Mahmoudabadi, A. Otomycosis in Iran: A Review. Mycopathologia 179, 415–424 (2015). https://doi.org/10.1007/s11046-015-9864-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11046-015-9864-7

Keywords

Navigation